Pertuzumab and Trastuzumab hyaluronidase (Phesgo)
Jump to navigation
Jump to search
General information
A combination of pertuzumab and trastuzumab, to be given by subcutaneous injection
History of changes in FDA indication
- 2020-06-29: Initial FDA approval
History of changes in EMA indication
- 2020-12-21: Initial authorization
Also known as
- Generic name: pertuzumab/trastuzumab/hyaluronidase-zzxf
- Brand name: Phesgo